PIII

P3 runs a Medicare Advantage capitation model — predictable PMPM revenue across ~2,400 PCPs and ~115,100 at-risk members in 23 markets — but the economics have never worked. The company has lost money every year shown (FY2021 -$146M through FY2025 -$148M), and FY2025 marked a turn from scaling to shrinking: revenue fell 2.8% to $1.46B while the operating loss stayed enormous at -$270M (-18.5% operating margin). In a full-risk capitation model, being responsible for 'all members' medical costs across the care continuum' means medical-cost overruns flow straight to the bottom line, and five straight years of red ink say P3 has not solved that equation.

The balance sheet is the disqualifier. Stockholders' equity is negative -$155M against -$651M of accumulated deficit; liabilities of $797M (up 25.7%) now exceed assets of $657M. Long-term debt more than doubled to $228M while cash fell 35.6% to just $25.0M — and operating cash flow was -$91.2M for the year. Roughly $25M of cash against ~$91M of annual operating burn implies a runway measured in months, with current liabilities ($545M) towering over current assets ($133M) for a ~$412M working-capital hole. This is a liquidity-and-solvency story, and it points to dilution, refinancing on punitive terms, or restructuring.